Apelin-13

Unknown Manufacturer

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Apelin polypeptides
US 12679868 B2Applicant: AMGEN INCPriority: 2014
EP
US
4 publications
APELIN-13 POLYPEPTIDE MUTANT
- WO 2024244719 A1
  Applicant: UNIV ZHEJIANGPriority: 2023
  CN
  WO
  3 publications
- WO 2026007693 A1
  Applicant: UNIV ZHEJIANGPriority: 2024
  WO
  2 publications
Synthetic linear apelin mimetics for the treatment of heart failure
US 10005829 B2Applicant: NOVARTIS AGPriority: 2013
CN
US
2 publications
Apelin peptides and uses thereof
US 10640545 B2Applicant: UNIV ALBERTAPriority: 2018
US
2 publications
APJ RECEPTOR AGONISTS AND USES THEREOF
EP 3907237 A1Applicant: AMGEN INCPriority: 2012
EP
Application of Apelin-13 to treatment of diabetic nephropathy
CN 104436158 AApplicant: UNIV HUAZHONG SCIENCE TECHPriority: 2013
CN
Apelin analogues
US 10118954 B2Applicant: UNIV ULSTERPriority: 2014
US
Freeze-dried powder for treating focal cerebral ischemia reperfusion inflammation reaction and preparation method thereof
CN 104399064 AApplicant: JINING MEDICAL UNIVERSITYPriority: 2014
CN
[Pyr1]‑Apelin‑13作为长效酰胺类局麻药中毒所致心脏停搏的抢救药物的应用
CN 106421746 BApplicant: 温州医科大学附属第医院Priority: 2016
CN
抗HIV药物可比司它用于制备抗血栓药物的用途
CN 108703971 BApplicant: 南华大学Priority: 2017
CN